vaccination with a Hybrid 1 (H1) fusion protein combined with a liposomal adjuvant (VAF01) induced antigen specific T-cells 3 years post vaccination in a human clinical trial.
JOURNAL OF IMMUNOLOGY（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要